Bevacizumab vs Dacarbazine in Metastatic Melanoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
The Norwegian Melanoma Group
The Norwegian Cancer Association
Information provided by (Responsible Party):
Haukeland University Hospital
ClinicalTrials.gov Identifier:
NCT01705392
First received: October 8, 2012
Last updated: December 3, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2018
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)